Myriad Genetics

Highly Engaged Employees

Myriad Genetics, founded in 1991, is a prominent American molecular diagnostic company. It specializes in the discovery and delivery of innovative tests across major disease areas, including oncology, hereditary cancer, and mental health. The company's core mission revolves around empowering patients and healthcare providers with precise genetic insights to guide better treatment decisions and improve patient outcomes. With a strong focus on scientific rigor and commercialization, Myriad Genetics has established itself as a leader in personalized medicine.

Operating with a workforce of 1,000 - 5,000 employees, Myriad Genetics leverages its extensive research and development capabilities to expand its product pipeline. The company is dedicated to advancing the understanding and management of complex diseases through its proprietary technologies and diagnostic platforms. Its commitment to innovation is reflected in its continuous efforts to develop novel tests that address unmet clinical needs. Meet Myriad Genetics's team to learn more about the professionals driving these advancements.

Myriad Genetics's strategic directives aim for organic growth and the expansion of its market presence. The company's revenue stands at $829.0M, underscoring its significant financial standing within the biotechnology sector. It competes with major players in the molecular diagnostics and genetic testing landscape, focusing on delivering high-quality, actionable data. The company's product suite includes tests for conditions such as hereditary breast, ovarian, and colorectal cancers, as well as mental health disorders, providing critical information for disease risk assessment and management.